NanoViricides Inc. (NNVC)

[nnvcbob]

NanoViricides Up 5.1%, Shares Break Through Resistance (NNVC)


Written on Mon, 06/08/2015 - 11:24am
By Nick Russo
NanoViricides ( NASDAQ:NNVC) is one of today's best performing low-priced stocks, up 5.1% to $2.25 on 1.2x average daily volume. NanoViricides has traded 245,000 shares thus far today, vs. average volume of 205,000 shares per day. The stock has outperformed the Dow (5.1% to the Dow's -0.2%) and outperformed the S&P 500 (5.1% to the S&P's -0.2%) during today's trading.

NanoViricides, Inc. is a biopharmaceutical company. The Company researches treatments for viruses such as AIDS/HIV, Hepatitis C, influenza, and Asian bird flu.

There is potential upside of 211.1% for shares of NanoViricides based on a current price of $2.25 and an average consensus analyst price target of $7.00. The stock should hit resistance at its 200-day moving average (MA) of $2.83, as well as support at its 50-day MA of $1.91.

Over the past year, NanoViricides has traded in a range of $1.44 to $4.77 and is now at $2.25, 56% above that low. In the last five trading sessions, the 50-day moving average (MA) has fallen 3.9% while the 200-day MA has slid 2%.

SmarTrend is monitoring the recent change of momentum in NanoViricides . Please refer to our Company Overview for the results of our proprietary technical indicators that have been scanning shares of NanoViricides in search of a potential trend change.